Beyond Air Inc
For the period ended Mar 31, 2025. Filed Jun 20, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Jun 20, 2025
XAIR$2.52+10.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Changes in Stockholders’ Equity
FOR THE YEAR ENDED MARCH 31, 2024
| Common Stock · Treasury · Additional Paid-in · Accumulated · Accumulated Other Comprehensive · Non-Controlling · Total | ||||||||
|---|---|---|---|---|---|---|---|---|
| Number | Amount | Stock | Capital | Deficit | Income/(Loss) | Interest | Equity | |
| Balance as of April 1, 2023 | 30,738,585 | $3 | $(25) | $217,339 | $(179,455) | $53 | $4,113 | $42,028 |
| Issuance of common stock – At The Market equity offering | 5,131,780 | 1 | - | 13,376 | - | - | - | 13,377 |
| Issuance of common stock – securities purchase agreement | 9,638,556 | 1 | - | 14,589 | - | - | - | 14,590 |
| Issuance of common stock upon exercise of options | 42,500 | - | - | 217 | - | - | - | 217 |
| Vested restricted stock | 349,400 | - | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | 19,259 | - | - | 2,078 | 21,337 |
| Other comprehensive loss | - | - | - | - | - | (68) | - | (68) |
| Net loss | - | - | - | - | (60,242) | - | (4,053) | (64,295) |
| Balance as of March 31, 2024 | 45,900,821 | $5 | $(25) | $264,780 | $(239,697) | $(15) | $2,138 | $27,186 |
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
FOR THE YEAR ENDED MARCH 31, 2025
| Common Stock · Treasury · Additional Paid-in · Accumulated · Accumulated Other Comprehensive · Non- Controlling · Total | ||||||||
|---|---|---|---|---|---|---|---|---|
| Number | Amount | Stock | Capital | Deficit | Income | Interest | Equity | |
| Balance as of April 1, 2024 | 45,900,821 | $5 | $(25) | $264,780 | $(239,697) | $(15) | $2,138 | $27,186 |
| Issuance of common stock – At The Market equity offering | 6,742,011 | 1 | - | 2,150 | - | - | - | 2,151 |
| Sale of common stock and pre-funded warrants | 24,999,999 | 2 | - | 18,856 | - | - | - | 18,858 |
| Issue of common stock warrants | - | - | - | 3,159 | - | - | - | 3,159 |
| Issuance of common stock upon exercise of warrants | 4,683,095 | - | - | 365 | - | - | - | 365 |
| Issuance of common stock upon vesting of restricted shares | 244,800 | - | - | - | - | - | - | - |
| NeuroNos issuance of stock | - | - | - | 1,765 | - | - | 235 | 2,000 |
| Stock-based compensation | - | - | - | 8,907 | - | - | 239 | 9,146 |
| Other comprehensive loss | - | - | - | - | - | (45) | - | (45) |
| Net loss | - | - | - | - | (46,625) | - | (1,854) | (48,479) |
| Balance as of March 31, 2025 | 82,570,726 | $8 | $(25) | $299,982 | $(286,322) | $(60) | $758 | $14,341 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.